Continuing Medical Education For HCPs

Staying updated with the latest advancements in cancer health is essential for healthcare professionals. Our Continuing Medical Education (CME) resources offer in-depth insights into the evolving landscape of oncology. Explore a range of educational materials designed to empower medical professionals with the knowledge needed to offer the best possible care to patients dealing with cancer. Stay informed about the latest treatment approaches, research findings, and innovative therapies.

Sponsored By

Effects of Prehabilitation on Postoperative Recovery

The study to be carried out in the Istanbul Faculty of Medicine Department of Anesthesiology was planned as a randomized, prospective study.
Patients who will undergo lung resection will be in ...

Condition: Lung Cancer

Acceptability of an Updated Version of the Untire mHealth App.

The goal of this clinical trial is to compare and measure acceptability and engagement between two versions of an app-based intervention (Untire app) designed to help adults with cancer related fat ...

Condition: Cancer-related Problem/Condition

To Explore the Benefits of the MonaLisa Touch´┐Ż System in Gynaecological Cancer Patients Treated by (Chemo)-RT

The increasing survival rate of gynaecological cancer patients highlights the need to improve their Quality of Life (QoL) after treatment.
Among all QoL factors, sexuality is unfortunately often ...

Condition: Gynecologic Cancer

Molecular Markers in Urinary Bladder Cancer: Applications for Diagnosis, Prognosis and Therapy

Cancer of the urinary bladder is a neoplasm with considerable importance in veterinary medicine, given its high incidence in several domestic animal species and its life-threatening character. Bladder

Tumor Growth Progression in Ectopic and Orthotopic Xenografts from Inflammatory Breast Cancer Cell Lines

Xenografts can grow in immunosuppressed hosts, such as SCID mice, and tumor material can be injected into hosts either ectopically or orthotopically. Choosing the correct model to use is a crucial ste

Effect of Dickkopf-1 (Dkk-1) and SP600125, a JNK Inhibitor, on Wnt Signaling in Canine Prostate Cancer Growth and Bone Metastases

Human Dickkopf-1 (Dkk-1) upregulates a noncanonical Wnt/JNK pathway, resulting in osteoclast stimulation, cell proliferation, and epithelial-to-mesenchymal transition (EMT) of cancer cells. Ace-1-Dkk-

Dr. Sara May, Allergy and Immunology

WCPH: Prostate Cancer Screenings

Leave it to the Professionals. In the US, 4 out of 10 individuals will encounter cancer. In Whitman County, 24% of new cancer ...

Dr. Sara May, Allergy and Immunology

Colorectal Cancer - When Is Chemotherapy Needed?

March is Colorectal Cancer Awareness Month and screening and prevention are so important for this disease. Doctorpedia is ...

Dr. Sara May, Allergy and Immunology

Meet Karim Kader, MD, PhD: Urologist and Urologic Cancer Specialist

More about Dr. Kader: Karim Kader, MD, PhD, is a board-certified ...